CTOs on the Move

Wesleyan Nursing Home

www.wesleyanhomes.org

 
Wesleyan Nursing Home is a Georgetown, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

St. John's

St. Johns Lutheran Community is a senior living community in Albert Lea, MN that provides short term care, skilled nursing care, independent living, assisted living, and memory care homes.

Rice Home Medical

Rice Home Medical is a Willmar, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TytoCare

TytoCare Ltd. is a consumer-focused telehealth company, offering state-of-the-art, patented devices and platform that empower anyone, anywhere and anytime to perform a variety of medical examinations and seamlessly consult with a clinician. The company was founded by Dedi Gilad, Ofer Tzadik and industry experts in 2012. Investors include OrbiMed Advisors, Walgreens, Cambia Health Solutions, Fosun Pharma, LionBird, Teuza VC and others.

Angel Care Home Health Care

Angel Care Home Health Care is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.